Predictors of lack of glycemic control in persons with type 2 diabetes
Judy Z Louie1, Dov Shiffman1, Charles M Rowland1
1Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA.
Insights
Many people with type 2 diabetes mellitus struggle to improve their HbA1c levels. Socioeconomic factors like race, income, and insurance significantly impact diabetes management and glycemic control.
Area of Science:
- Endocrinology
- Public Health
- Health Disparities
Background:
- Professional guidelines recommend HbA1c <7% for most with diabetes, and <8.5% for those with relaxed goals.
- A significant number of individuals with type 2 diabetes mellitus (T2DM) do not achieve their target HbA1c.
- This study investigates factors contributing to the lack of HbA1c improvement over three years.
Purpose of the Study:
- To identify predictors of poor glycemic control in T2DM patients.
- To explore the association between socioeconomic factors and the inability to improve HbA1c.
- To inform targeted interventions for underserved populations with T2DM.
Main Methods:
- Analysis of T2DM patients (2015-2020) with HbA1c >8.5% within three years.
- Categorization into improved glycemic control (HbA1c ≤8.5%) or lack of improvement (HbA1c >8.5%).
- Multivariate logistic regression to determine independent predictors of poor glycemic control.
Main Results:
- Younger age, female gender, hypertension, Black race, low income, and non-Medicare insurance were associated with lack of HbA1c improvement.
- Living in low-income areas showed a strong association with poorer glycemic control (OR 1.86).
- Current smoking paradoxically correlated with HbA1c improvement, but this was not significant in subgroup analysis.
Conclusions:
- Socioeconomic factors, including race, insurance type, and income level, are significantly linked to poor HbA1c control in T2DM.
- Intervention strategies must address socioeconomic determinants to improve diabetes management, particularly in low-income communities.
- Targeted public health initiatives are crucial for enhancing diabetes care in vulnerable populations.
Background:
Professional guidelines recommend an HbA1c < 7% for most people with diabetes and < 8.5% for those with relaxed glycemic goals. However, many people with type 2 diabetes mellitus (T2DM) are unable to achieve the desired HbA1c goal. This study evaluated factors associated with lack of improvement in HbA1c over 3 years.
Methods:
All patients with T2DM treated within a major academic healthcare system during 2015-2020, who had at least one HbA1c value > 8.5% within 3 years from their last HbA1c were included in analysis. Patients were grouped as improved glycemic control (last HbA1c ≤ 8.5%) or lack of improvement (last HbA1c > 8.5%). Multivariate logistic regression analysis was performed to assess independent predictors of lack of improvement in glycemic control.
Results:
Out of 2,232 patients who met the inclusion criteria, 1,383 had an improvement in HbA1c while 849 did not. In the fully adjusted model, independent predictors of lack of improvement included: younger age (odds ratio, 0.89 per 1-SD [12 years]; 95% CI, 0.79-1.00), female gender (1.30, 1.08-1.56), presence of hypertension (1.29, 1.08-1.55), belonging to Black race (1.32, 1.04-1.68, White as reference), living in low income area (1.86,1.28-2.68, high income area as reference), and insurance coverage other than Medicare (1.32, 1.05-1.66). Presence of current smoking was associated with a paradoxical improvement in HbA1c (0.69, 0.47-0.99). In a subgroup analysis, comparing those with all subsequent HbA1c values > 8.5% (N = 444) to those with all subsequent HbA1c values < 8.5% (N = 341), similar factors were associated with lack of improvement, but smoking was no longer significant.
Conclusion:
We conclude that socioeconomic factors like race, type of insurance coverage and living in low-income areas are associated with lack of improvement in HbA1c over a period of 3-years in people with T2DM. Intervention strategies focused on low-income neighborhoods need to be designed to improve diabetes management.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


